In the ever-evolving field of diabetes management, GLP-1 receptor agonists have emerged as a transformative therapeutic class. Among these, retaglutide, retatrutide, and trizepatide represent promising additions to the https://darrendubu215350.blog2freedom.com/39205390/the-emerging-landscape-of-glp-1-receptor-agonists-retaglutide-retatrutide-and-trizepatide